Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial
NCT ID: NCT07316946
Last Updated: 2026-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
62 participants
INTERVENTIONAL
2026-02-13
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Kinesio Taping in Musculoskeletal Neck Pain
NCT04916366
Dry Needling in Subjects With Delayed Onset Muscle Soreness
NCT03876080
Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Upper Limb: a Double-blind Randomized Clinical Trial
NCT07165392
Muscle Stretching - the Potential Role of Endogenous Pain Inhibitory Modulation on Stretch Tolerance
NCT03713788
Percutaneous Electrical Nerve Stimulation and Exercise for Shoulder Pain
NCT06158568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo group
The placebo group will receive the same bandage, with the same strip arrangement, but without any tension (0%) applied to any of the strips. Furthermore, participants will not receive any instructions for muscle activation during application. This placebo technique has been used in previous studies, supporting its methodological validity.
Placebo Group
The placebo group will receive the same taping, with an identical arrangement of the strips, but without applying any tension (0%) to them. In addition, participants will not receive any instructions regarding muscle activation during the application. This placebo taping model has been used in previous studies, supporting its methodological validity.
Experimental group
The experimental group will receive neuromuscular taping with kinesiology tape, consisting of two longitudinal strips applied along the lower trapezius muscle, with a tension close to 100% of the tape's elastic capacity. During application, the participant will be asked to activate the scapular depressor and retractor muscles.
Additionally, two more longitudinal strips will be applied from the anterior portion of the humeral head towards the scapular spine, also with a tension close to 100%. During this application, the participant will be asked to activate the rotator cuff by applying a posteroanterior push to the humeral head.
Experimental Group
The experimental group will receive a multilayer neuromuscular taping application using kinesiotape, consisting of the placement of two longitudinal strips in the direction of the lower trapezius, applied with tension close to 100% of the tape's elastic capacity. During the application, participants will be asked to activate the scapular depressor and retractor muscles.
Additionally, two other longitudinal strips will be applied from the anterior portion of the humeral head toward the scapular spine, also with tension close to 100%. During this application, participants will be asked to activate the rotator cuff through a posteroanterior push of the humeral head.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental Group
The experimental group will receive a multilayer neuromuscular taping application using kinesiotape, consisting of the placement of two longitudinal strips in the direction of the lower trapezius, applied with tension close to 100% of the tape's elastic capacity. During the application, participants will be asked to activate the scapular depressor and retractor muscles.
Additionally, two other longitudinal strips will be applied from the anterior portion of the humeral head toward the scapular spine, also with tension close to 100%. During this application, participants will be asked to activate the rotator cuff through a posteroanterior push of the humeral head.
Placebo Group
The placebo group will receive the same taping, with an identical arrangement of the strips, but without applying any tension (0%) to them. In addition, participants will not receive any instructions regarding muscle activation during the application. This placebo taping model has been used in previous studies, supporting its methodological validity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* compete in a sport that involves overhead movement patterns
* train at least 2 hours per week
* shoulder pain lasting more than six weeks
* shoulder pain related to sports activity
* understand Spanish fluently enough to complete the questionnaire assessment.
Exclusion Criteria
* neurological pathologies
* other severe pathologies such as inflammatory arthritis, frozen shoulder
* having received corticosteroid injections or physiotherapy treatment in the last six months
* presence of previous surgeries
* pregnancy
* cognitive deficits that could limit the comprehension of the questionnaires or the physical evaluation
* skin problems that would be a contraindication for any type of bandage.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sandra Jiménez-del-Barrio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra Jiménez-del-Barrio
PhD Physiotherapist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Health Sciences
Soria, Soria, Spain
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REF CEIm
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.